| Full Name | John E Hess |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 18 Years |
| Location | 410 N Malacate St, Ajo, Arizona |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720171556 | NPI | - | NPPES |
| 1720171556 | Other | FL | NPI |
| A0806308 | Other | FL | NP-C |
| SSN | Other | FL | TRICARE |
| 366988 | Other | HEALTHEASE/HEALTHYKIDS | |
| 307964300 | Medicaid | FL | |
| ARNP9206510 | Other | FL | LICENSE NUMBER |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363L00000X | Nurse Practitioner | ARNP9206510 (Florida) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ajo Community Health Center | 3476441866 | 11 |
News Archive
Neuralstem, Inc. announced today that it has entered into definitive agreements to sell $10 million of units at $2.80 per unit in a registered-direct offering to institutional investors. The units consist of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years.
A senior adviser to President Barack Obama says the government "overpromised" with the swine flu vaccine but that the vaccine supply would catch up with the demand within a week. Meanwhile, a health group established to monitor the vaccine's safety will begin work this week.
Sarnova, Inc., the nation's leading specialty distributor of health care products in the emergency medical services (EMS) and respiratory markets, announced today that it has acquired CVC, Inc. Headquartered in Arlington, Texas, CVC is a supplier of products to the acute care respiratory and emergency medical services markets.
Researchers at NYU Langone Medical Center today announce findings published in the October 20 issue of Nature that show for the first time the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with chemically modified anti-miR oligonucleotides markedly suppress triglyceride levels and cause a sustained increase in high density lipoprotein cholesterol (HDL-C) "good" cholesterol.
Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 5 days ago
| Entity Name | Ajo Community Health Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114037496 PECOS PAC ID: 3476441866 Enrollment ID: O20040308000777 |
News Archive
Neuralstem, Inc. announced today that it has entered into definitive agreements to sell $10 million of units at $2.80 per unit in a registered-direct offering to institutional investors. The units consist of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years.
A senior adviser to President Barack Obama says the government "overpromised" with the swine flu vaccine but that the vaccine supply would catch up with the demand within a week. Meanwhile, a health group established to monitor the vaccine's safety will begin work this week.
Sarnova, Inc., the nation's leading specialty distributor of health care products in the emergency medical services (EMS) and respiratory markets, announced today that it has acquired CVC, Inc. Headquartered in Arlington, Texas, CVC is a supplier of products to the acute care respiratory and emergency medical services markets.
Researchers at NYU Langone Medical Center today announce findings published in the October 20 issue of Nature that show for the first time the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with chemically modified anti-miR oligonucleotides markedly suppress triglyceride levels and cause a sustained increase in high density lipoprotein cholesterol (HDL-C) "good" cholesterol.
Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John E Hess, ARNP 410 N Malacate St, Ajo, AZ 85321-2254 Ph: (520) 387-5651 | John E Hess, ARNP 410 N Malacate St, Ajo, AZ 85321 Ph: (520) 387-5651 |
News Archive
Neuralstem, Inc. announced today that it has entered into definitive agreements to sell $10 million of units at $2.80 per unit in a registered-direct offering to institutional investors. The units consist of: (i) one share of common stock, and (ii) 3/4 common stock purchase warrant. The warrants have an exercise price of $3.25 and a term of three years.
A senior adviser to President Barack Obama says the government "overpromised" with the swine flu vaccine but that the vaccine supply would catch up with the demand within a week. Meanwhile, a health group established to monitor the vaccine's safety will begin work this week.
Sarnova, Inc., the nation's leading specialty distributor of health care products in the emergency medical services (EMS) and respiratory markets, announced today that it has acquired CVC, Inc. Headquartered in Arlington, Texas, CVC is a supplier of products to the acute care respiratory and emergency medical services markets.
Researchers at NYU Langone Medical Center today announce findings published in the October 20 issue of Nature that show for the first time the inhibition of both microRNA-33a and microRNA-33b (miR-33a/b) with chemically modified anti-miR oligonucleotides markedly suppress triglyceride levels and cause a sustained increase in high density lipoprotein cholesterol (HDL-C) "good" cholesterol.
Saint Louis University is leading a multi-national clinical trial of what could become a regimen for drug resistant tuberculosis (TB) that does not require injectable medications. The project is funded by a $6.4 million task order from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health.
› Verified 5 days ago
Mrs. Debra D Leonard, FNP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 410 N Malacate St, Ajo, AZ 85321 Phone: 520-387-5651 |